A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Current treatment strategies for Hodgkin lymphoma result in excellent survival but often confer significant long-term toxicity. We designed ABVE-PC (doxorubicin, bleomycin, vincristine, etoposide, prednisone, cyclophosphamide) to (1) enhance treatment efficacy by dose-dense drug delivery and (2) red...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schwartz, Cindy L., Constine, Louis S., Villaluna, Doojduen, London, Wendy B., Hutchison, Robert E., Sposto, Richard, Lipshultz, Steven E., Turner, Charles S., deAlarcon, Pedro A., Chauvenet, Allen
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744567/
https://ncbi.nlm.nih.gov/pubmed/19584400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-184143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados